Renew X Pharma Launches Cutting-Edge Online Platform for Premium Wellness Products
05. November 2024 15:35 ET
|
Renew X Pharma
Vancouver, Canada, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Renew X Pharma has launched a new website, offering a user-friendly platform for individuals seeking reliable wellness products. From...
Time Running Out: Three Weeks Left to Join JimStoppani.com's $25,000 Holiday Shred Challenge
28. Oktober 2024 17:56 ET
|
JimStoppani.com
Westlake Village, CA, Oct. 28, 2024 (GLOBE NEWSWIRE) -- JimStoppani.com, a leading fitness and nutrition platform, announces that only three weeks remain for fitness enthusiasts to register for the...
New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Serious Side Effects
24. Oktober 2024 08:30 ET
|
FirstFitness Nutrition
New Study Finds Trimsulin Achieves 243% Greater Weight Loss than Semaglutide without Side Effects Offering a Natural GLP-1 Alternatative for Weight Loss.
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Engages Leading Contract Research Organization (CRO) to Support Regulatory Planning Efforts and Pre-IND Meeting with the Food and Drug Administration For EL-22 For The Treatment of Obesity
22. Oktober 2024 09:54 ET
|
Elevai Labs Inc.
Elevai Biosciences Engages Leading CRO to Support Regulatory Planning Efforts and Pre-IND Meeting with the FDA for EL-22 For The Treatment of Obesity
Weight Management Report 2024: Consumer Mindsets & Actions - Market-Level Nuances on Weight, Dieting and Exercise
22. Oktober 2024 07:42 ET
|
Research and Markets
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Weight Management: Consumer Mindsets & Actions - Market-Level Nuances on Weight, Dieting, & Exercise" report has been added to ...
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Blocker, For the Treatment of Obesity
21. Oktober 2024 07:30 ET
|
Elevai Labs Inc.
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Highlights Past Positive Preclinical Data Showing Potential of EL-32, A Dual Myostatin & Activin-A Bl
Sesame, America’s Low-Cost Leader in Healthcare, Is First Major Direct-to-Consumer Weight Loss Company to Offer Compounded Semaglutide to All 50 United States
16. Oktober 2024 08:05 ET
|
Sesame
NEW YORK CITY, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Sesame, the company that offers Americans quality, convenient health care at half the typical price, today announced that it has begun offering...
Canada Weight Management and Wellbeing Market Analysis, 2019-2028: Developments, Trends, Opportunities, Shares, Sales, and Growth Forecasts
16. Oktober 2024 05:48 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Weight Management and Wellbeing in Canada" report has been added to ResearchAndMarkets.com's offering.Weight management and wellbeing is set to see...
Weight Loss Services Market Analysis Report 2024-2030, Featuring Profiles of Atkins Nutritionals, Precor, Apollo Endosurgery, Johnson Health Tech, Life Fitness, iFIT, Torque Fitness and More
15. Oktober 2024 12:54 ET
|
Research and Markets
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Weight Loss Services Market Size, Share and Trends Analysis Report by Function (Fitness Equipment, Surgical Equipment, Services), Payment...
WeightWatchers Adds Compounded GLP-1, Expanding Accessibility and Affordability of Weight Loss Medications
08. Oktober 2024 09:00 ET
|
WW International Inc.
NEW YORK, Oct. 08, 2024 (GLOBE NEWSWIRE) -- WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering,...